You are viewing an incomplete version of our website. Please click to reload the website as full version.

Browse our anti-PAG1 (PAG1) Antibodies

Full name:
anti-phosphoprotein Associated with Glycosphingolipid Microdomains 1 Antibodies (PAG1)
On are 97 phosphoprotein Associated with Glycosphingolipid Microdomains 1 (PAG1) Antibodies from 12 different suppliers available. Additionally we are shipping PAG1 Proteins (4) and PAG1 Kits (3) and many more products for this protein. A total of 107 PAG1 products are currently listed.
8430414N03Rik, Cbp, F730007C19Rik, IGFBP-4ase, MGC80192, Pag, PAG1, PAPP-A

All available anti-PAG1 Antibodies

Go to our pre-filtered search.

Top referenced anti-PAG1 Antibodies

  1. Human Monoclonal PAG1 Primary Antibody for FACS, IHC (p) - ABIN94272 : Yerly, Ding, Tauzin, van Echten-Deckert, Borisch, Hoessli: The sphingolipid-rich rafts of ALK+ lymphomas downregulate the Lyn-Cbp/PAG signalosome. in European journal of haematology 2010 (PubMed)
    Show all 6 references for ABIN94272

  2. Human Monoclonal PAG1 Primary Antibody for IHC (p), IP - ABIN94270 : Baumgartner, Angelisová, Setterblad, Mooney, Werling, Horejsí, Langsley: Constitutive exclusion of Csk from Hck-positive membrane microdomains permits Src kinase-dependent proliferation of Theileria-transformed B lymphocytes. in Blood 2003 (PubMed)
    Show all 5 references for ABIN94270

  3. Cow (Bovine) Monoclonal PAG1 Primary Antibody for IHC (p), IP - ABIN269119 : Yamashita, Chattopadhyay, Fensterl, Zhang, Sen: A TRIF-independent branch of TLR3 signaling. in Journal of immunology (Baltimore, Md. : 1950) 2012 (PubMed)

  4. Human Monoclonal PAG1 Primary Antibody for FACS, IHC (p) - ABIN120652 : Brdicková, Brdicka, Andera, Spicka, Angelisová, Milgram, Horejsí: Interaction between two adapter proteins, PAG and EBP50: a possible link between membrane rafts and actin cytoskeleton. in FEBS letters 2001 (PubMed)

More Antibodies against PAG1 Interaction Partners

Human phosphoprotein Associated with Glycosphingolipid Microdomains 1 (PAG1) interaction partners

  1. Up-regulated expression of CBP (show CREBBP Antibodies) in Jurkat cells could reduce cell homogeneity and promote cell apoptosis

  2. No association Pag1 mutation with patient with Schizophrenia.

  3. The risk-associated allele of rs2370615 predisposes to allergic disease by increasing PAG1 expression, which might promote B cell activation (show BLNK Antibodies) and have a pro-inflammatory effect.

  4. CBP (show CREBBP Antibodies) may decrease the metastasis of esophageal carcinoma by inhibiting the activation of Src (show SRC Antibodies).

  5. The inhibitory function of novobiocin in disrupting the HIF1alpha (show HIF1A Antibodies)/p300 (show EP300 Antibodies) complex might be important in tumor cell growth.

  6. siRNA directed against PAG1 in a radioresistant (Hep-2max) cell line dramatically enhanced the radiosensitivity and IR-induced cell death.

  7. expression of CBP (show CREBBP Antibodies) gene is decreased in esophageal carcinoma, which might contribute to the tumorigenesis and progression.

  8. An over-expression of PAG1 in PC-3M-1E8 cells effectively suppresses the activation of Ras and ERK (show EPHB2 Antibodies), as well as the cyclin D1 (show CCND1 Antibodies) expression, leading to an inhibition of the proliferation ability of tumor cells.

  9. Cbp (show CREBBP Antibodies) down-regulation is primarily mediated by epigenetic histone modifications via oncogenic MAPK (show MAPK1 Antibodies)/PI3K (show PIK3CA Antibodies) pathways in a subset of cancer cells.

  10. Results indicate that Cbp is required for the Csk-mediated inactivation of c-Src and may control the promotion of malignancy in NSCLC tumors that are characterized by c-Src upregulation.

Mouse (Murine) phosphoprotein Associated with Glycosphingolipid Microdomains 1 (PAG1) interaction partners

  1. Study demonstrates proof-of-principle and provides feasibility for a novel therapeutic strategy to inhibit atherosclerotic plaque burden by selective targeting of PAPP-A (show PAPPA Antibodies).

  2. stimulation of PAPP-A (show PAPPA Antibodies) expression by intermittent PTH (show PTH Antibodies) treatment contributes to PTH (show PTH Antibodies) bone anabolism in mice

  3. PAPP-A (show PAPPA Antibodies) affects fascicle structure, thereby affecting tendon phenotype.

  4. This study demonstrated that cbp (show CREBBP Antibodies) increase in skeletal muscle in muscle atrophy.

  5. PAG is constitutively phosphorylated in resting T cells and rapidly dephosphorylated once the TCR is engaged.

  6. If Cbp enhances the interaction between c-Src and FAK, Cbp could promote c-Src function when lipid rafts are disrupted.

  7. PAG (show PRDX1 Antibodies) can function as both a positive and a negative regulator of mast cell signaling, depending upon the signaling pathway involved. PAG (show PRDX1 Antibodies) is a positive regulator of passive systemic anaphylaxis.

  8. PAPP-A (show PAPPA Antibodies) has a role in development of advanced plaque with necrotic cores and buried fibrous caps (show CAPS Antibodies) in the brachiocephalic artery

  9. these data indicate preferential impact of PAPP-A (show PAPPA Antibodies) deficiency on visceral fat in the mouse that is associated with enhanced insulin receptor (show INSR Antibodies) signaling

  10. Studies show a conditional PAPP-A (show PAPPA Antibodies) knockout (KO) model for efficacy of tamoxifen-induced floxed PAPP-A (show PAPPA Antibodies) excision in various tissues and indicate a significant reduction of neointimal formation after unilateral carotid artery ligation.

PAG1 Antigen Profile

Antigen Summary

The protein encoded by this gene is a type III transmembrane adaptor protein that binds to the tyrosine kinase csk protein. It is thought to be involved in the regulation of T cell activation.

Alternative names and synonyms associated with PAG1

  • phosphoprotein associated with glycosphingolipid microdomains 1 (PAG1) antibody
  • phosphoprotein associated with glycosphingolipid microdomains 1 (pag1) antibody
  • phosphoprotein associated with glycosphingolipid microdomains 1 (Pag1) antibody
  • pregnancy-associated plasma protein A (Pappa) antibody
  • 8430414N03Rik antibody
  • Cbp antibody
  • F730007C19Rik antibody
  • IGFBP-4ase antibody
  • MGC80192 antibody
  • Pag antibody
  • PAG1 antibody
  • PAPP-A antibody

Protein level used designations for PAG1

phosphoprotein associated with glycosphingolipid microdomains 1 , phosphoprotein associated with glycosphingolipid-enriched microdomains 1-like , Csk-binding protein , phosphoprotein associated with glycosphingolipid-enriched microdomains 1 , transmembrane adapter protein PAG , transmembrane adaptor protein PAG , transmembrane phosphoprotein Cbp , Csk binding protein , csk-binding protein , phosphoprotein transmembrane adaptor 1 , phosphoprotein-associated with GEMs , IGF-dependent IGFBP-4 protease , insulin-like growth factor-dependent IGF-binding protein 4 protease , pappalysin-1

420195 Gallus gallus
446514 Xenopus laevis
464253 Pan troglodytes
610895 Canis lupus familiaris
700748 Macaca mulatta
100050548 Equus caballus
100380123 Xenopus (Silurana) tropicalis
100391406 Callithrix jacchus
100585162 Nomascus leucogenys
55824 Homo sapiens
614460 Bos taurus
64019 Rattus norvegicus
94212 Mus musculus
100157912 Sus scrofa
101112826 Ovis aries
18491 Mus musculus
Selected quality suppliers for anti-PAG1 (PAG1) Antibodies
Did you look for something else?